首页|蝉芩颗粒治疗咳嗽变异性哮喘的效果分析

蝉芩颗粒治疗咳嗽变异性哮喘的效果分析

扫码查看
目的 分析咳嗽变异性哮喘患者使用蝉岑颗粒进行治疗的效果.方法 66 例咳嗽变异性哮喘患者作为研究对象,在随机抽样法方式分成常规组及研究组,每组 33 例.常规组患者使用常规西药疗法,研究组使用常规西药联合蝉岑颗粒疗法.对比两组患者的治疗效果、不良反应发生率、咳嗽症状改善时间、中医症状评分、咳嗽症状积分、炎症介质水平.结果 研究组治疗总有效率 96.97%高于常规组的 78.79%(P<0.05).研究组不良反应发生率 3.03%低于常规组的 24.24%(P<0.05).研究组夜咳停止时间、咳嗽消退时间、咳嗽缓解时间分别为(6.30±1.18)、(11.41±4.31)、(5.01±1.31)d,短于常规组的(10.53±3.43)、(15.73±3.42)、(9.73±3.13)d(P<0.05).治疗后,研究组咳嗽、咽痒、痰量、鼻塞、喘息中医症状评分分别为(0.26±0.41)、(0.55±0.60)、(0.11±0.33)、(0.41±0.42)、(0.27±0.41)分,低于常规组的(0.78±0.82)、(1.24±0.94)、(0.71±0.63)、(0.89±0.86)、(0.55±0.64)分(P<0.05).治疗后,研究组日间咳嗽、夜间咳嗽、咳嗽总分分别为(0.67±0.72)、(0.33±0.42)、(1.00±1.20)分,低于常规组的(1.21±1.15)、(1.45±0.35)、(2.66±1.67)分(P<0.05).治疗后,研究组肿瘤坏死因子-α、白细胞介素-6、白细胞介素-10 水平分别为(0.54±0.02)μg/L、(16.18±2.65)ng/L、(3.75±0.84)ng/L,低于常规组的(0.89±0.46)μg/L、(20.79±4.49)ng/L、(7.13±1.44)ng/L(P<0.05).结论 咳嗽变异性哮喘患者使用蝉岑颗粒联合西药进行治疗,可以改善患者的咳嗽症状,促进患者疾病好转,临床应用价值较高.
Effect analysis of Chanqin granule in treating cough variant asthma
Objective To analyze the effect of Chanqin granule in treating cough variant asthma.Methods A total of 66 patients with cough variant asthma were studied and divided into a conventional group and a study group by random sampling method,with 33 cases in each group.The conventional group was treated with conventional Western medicine,and the study group was treated with conventional Western medicine combined with Chanqin granule.The therapeutic effect,incidence of adverse reactions,improvement time of cough symptoms,traditional Chinese medicine syndrome score,cough symptom score and inflammatory mediator levels between were compared between the two groups.Results The total effective rate of the study group was 96.97%,which was higher than 78.79%of the conventional group(P<0.05).The incidence of adverse reactions in the study group was 3.03%,which was lower than 24.24%in the conventional group(P<0.05).The time of cessation of nighttime cough,time of cough subsidence,and time of cough relief in the study group were(6.30±1.18),(11.41±4.31),and(5.01±1.31)d,which were shorter than(10.53±3.43),(15.73±3.42),and(9.73±3.13)d in the conventional group(P<0.05).After treatment,the traditional Chinese medicine syndrome scores of cough,pharyngeal itching,phlegm volume,nasal congestion,and wheezing in the study group were(0.26±0.41),(0.55±0.60),(0.11±0.33),(0.41±0.42),and(0.27±0.41)points,which were lower than(0.78±0.82),(1.24±0.94),(0.71±0.63),(0.89±0.86),and(0.55±0.64)points in the conventional group(P<0.05).After treatment,the daytime cough,nighttime cough,and total cough scores of the study group were(0.67±0.72),(0.33±0.42),and(1.00±1.20)points,which were lower than(1.21±1.15),(1.45±0.35),and(2.66±1.67)points of the conventional group(P<0.05).After treatment,the levels of tumor necrosis factor-α,interleukin-6,and interleukin-10 in the study group were(0.54±0.02)μg/L,(16.18±2.65)ng/L,and(3.75±0.84)ng/L,which were lower than(0.89±0.46)μg/L,(20.79±4.49)ng/L,and(7.13±1.44)ng/L in the conventional group(P<0.05).Conclusion The use of Chanqin granule combined with Western medicine in the treatment of patients with cough variant asthma can improve the cough symptoms of patients and promote the improvement of patients'disease,and has high clinical application value.

Chanqin granuleCough variant asthmaEfficacy

张焕芬

展开 >

271124 济南市莱芜区牛泉中心卫生院

蝉芩颗粒 咳嗽变异性哮喘 疗效

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(11)
  • 10